New US tariff plans on drug imports could shake the $13 billion Indian pharma exports to their core, jeopardising generics access and investor confidence alike. #Pharma #US #tradewar Read more »
India’s start-up ecosystem risks stagnation unless it shifts focus from convenience-driven apps to innovation-led growth. #Startups Read more »
With $20 bn IT deals near expiry, Indian IT firms are confronting a double bind of geopolitical tension and AI-driven disruption. #IT #Tradewar Read more »
India’s GDP growth numbers rely on questionable data sources and statistical discrepancies that cast doubt on their credibility. Read more »
The 90-day pause on tariff war reveals how investor panic and bond market tremors—not policy planning—pushed the White House into damage control. #trumprariffs #tradewar #usvschina Read more »
The government’s plan to revise rural inflation indices marks a shift in how economic hardship is measured and addressed. #ruralinflation #CPI Read more »
In an age of rising inequality and climate urgency, public sector undertakings offer developing nations a rare tool to align economic sovereignty with social and environmental justice. #PSUs #policy Read more »
A surge in third-country imports exploiting free trade agreements—especially from China via ASEAN—has prompted India to overhaul its origin verification regime. #FTAs #China #ASEAN Read more »
X has taken Union govt to court, alleging that India’s new content-blocking mechanism violates constitutional safeguards of free speech. #X #ElonMusk #freespeech Read more »
Indian economy continues to outperform peers, but sustaining growth will require deeper reforms and coordinated fiscal strategies. Read more »